ISRCTN12026431
Completed
N/A
Clinical evaluation of the effects of paediatric dental general anaesthesia and midazolam sedation on cognitive function, anxiety and access to future dental care
Scottish Executive Chief Scientist Office (UK)0 sites200 target enrollmentOctober 5, 2005
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Dental caries requiring multiple extractions
- Sponsor
- Scottish Executive Chief Scientist Office (UK)
- Enrollment
- 200
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Children aged 5\-10 years having multiple dental extractions under general anaesthesia due to their inability to cope with conscious sedation.
Exclusion Criteria
- •1\. English not first language
- •2\. Learning disability
- •3\. Neurological disorder
- •4\. Psychiatric disorder
- •5\. Respiratory disorder
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
Phase 3
Assessment of praziquantel medication for children living in areas where schistosomiasis is common in Bahia and SergipeRBR-86kcy37Instituto Gonçalo Moniz (IGM) - Fundação Oswaldo Cruz (Fiocruz-BA)
Completed
N/A
Paediatric onset study to assess the efficacy of insulin pump therapy using the MiniMed Paradigm® REAL-Time system during the first year of diabetes in children and adolescents with type 1 diabetesISRCTN05450731Hannover Childrens Hospital (Hannoversche Kinderheilanstalt) (Germany)160
Not Yet Recruiting
N/A
Comparing the 3 different instruments in cleaning the primary teethHealth Condition 1: A488- Other specified bacterial diseasesCTRI/2019/09/021033Kabita Sahoo
Active, Not Recruiting
Phase 1
A PAEDIATRIC PHASE I/II STUDY OF INTERMITTENT DOSING OF THE MEK-1 INHIBITOR SELUMETINIB IN CHILDREN WITH NEUROFIBROMATOSIS TYPE-1 AND INOPERABLE PLEXIFORM NEUROFIBROMA AND/OR PROGRESSIVE OPTIC PATHWAY GLIOMANeurofibromatosis type 1 associated plexiform neurofibromas Neurofibromatosis type 1 associated progressive or relapsed optic pathway gliomaMedDRA version: 20.0 Level: LLT Classification code 10029270 Term: Neurofibromatosis, type 1 (von Recklinghausen's disease) System Organ Class: 100000004850MedDRA version: 20.0 Level: LLT Classification code 10065866 Term: Plexiform neurofibroma System Organ Class: 100000004864MedDRA version: 20.0 Level: LLT Classification code 10030935 Term: Optic nerve glioma System Organ Class: 100000004864Therapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2017-002635-41-GBGreat Ormond Street Hospital38
Completed
N/A
A clinical study to evaluate to the effects of D-psicose (D-allulose) on respiratory metabolism (meal tolerance test)JPRN-UMIN000034213Soiken Inc.48